Studies have found that genistein treatment can alleviate the gene levels of IL‐17 in ovariectomized experimental periodontitis rats, increase the expression of tight junction proteins, and prevent the absorption of alveolar bone (Liu et al. 2022). Here, IL17A is linked to periodontitis.